Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) revealed a profit for first quarter that Dropped, from the same period last year
The company's bottom line totaled RMB172.084 million, or RMB0.19 per share. This compares with RMB250.202 million, or RMB0.28 per share, last year.
The company's revenue for the period fell 19.5% to RMB1.200 billion from RMB1.490 billion last year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB172.084 Mln. vs. RMB250.202 Mln. last year.-EPS: RMB0.19 vs. RMB0.28 last year.-Revenue: RMB1.200 Bln vs. RMB1.490 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.